Resources Contact Us Home
Ribonucleotide reductase inhibitors and methods of use

Image Number 18 for United States Patent #8372983.

Provided herein are novel compounds that inhibit ribonucleotide reductase (RR) by binding to RRM2 and interfering with the activity of the RRM1/RRM2 holoenzyme, as well as methods of synthesizing these novel compounds. The compounds may be used to inhibit RR activity and to treat various conditions associated with RRM2 expression, such as for example certain cancer types, mitochondrial diseases, or degenerative diseases.

  Recently Added Patents
Device and method for quantizing and inverse quantizing LPC filters in a super-frame
Apparatus for generating electrical energy from rocking activated energy
Organic electroluminescence device
Vehicle running control system
Moving structure and micro-mirror device using the same
Crowd validated internet document witnessing system
  Randomly Featured Patents
Guanidino, thioureido and isothioureido derivatives containing imidazole groups
Process for loading a shipping container with vehicles
Asymmetric cone beam
Radioimmunoassay assay and reagents for MB isoenzyme of CK
Interlocking roof system
Process for deodorizing isopropyl alcohol
Glycodendrimers having biological activity
Method and composition for plant preservation without leaf curling
Film for optical applications
Photoresist composition for deep ultraviolet lithography